Entera Bio Ltd. (ENTX)

Entera Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	65	17	21	81	20	26
Market Cap Growth	77.30%	-17.80%	-74.04%	308.59%	-23.75%	-24.94%
Enterprise Value	56	7	9	56	12	11
PE Ratio	-	-1.94	-1.61	-6.65	-1.77	-2.41
PS Ratio	-	-	156.95	141.91	54.33	110.21
PB Ratio	7.31	1.67	1.79	3.59	2.64	2.18
P/FCF Ratio	-7.83	-2.36	-1.68	-8.92	-1.87	-2.90
P/OCF Ratio	-7.83	-2.37	-1.68	-8.94	-1.88	-2.92
EV/Sales Ratio	-	-	65.77	98.84	31.97	47.13
EV/EBITDA Ratio	-5.84	-0.76	-0.68	-4.63	-1.05	-1.05
EV/EBIT Ratio	-5.81	-0.75	-0.68	-4.61	-1.04	-1.03
EV/FCF Ratio	-6.66	-0.91	-0.70	-6.22	-1.10	-1.24
Debt / Equity Ratio	0.04	0.04	0.01	0.01	0.06	0.03
Debt / EBITDA Ratio	-0.04	-0.04	-0.01	-0.02	-0.04	-0.03
Debt / FCF Ratio	-0.05	-0.05	-0.01	-0.03	-0.04	-0.03
Quick Ratio	8.20	10.10	9.36	7.93	4.81	3.37
Current Ratio	8.70	10.32	9.58	8.01	4.95	3.41
Asset Turnover	0	0	0.01	0.02	0.03	0.02
Return on Equity (ROE)	-103.40%	-101.80%	-82.90%	-59.80%	-147.10%	-143.50%
Return on Assets (ROA)	-85.00%	-83.90%	-74.60%	-47.50%	-99.40%	-97.10%
Return on Capital (ROIC)	-94.99%	-82.96%	-110.33%	-53.63%	-140.62%	-93.75%
Earnings Yield	-13.44%	-51.42%	-62.15%	-15.04%	-56.56%	-41.50%
FCF Yield	-11.68%	-42.38%	-59.65%	-11.21%	-53.50%	-34.45%
Buyback Yield / Dilution	-27.51%	-0.69%	-10.23%	-41.90%	-51.62%	-52.15%
Total Shareholder Return	-27.51%	-0.69%	-10.23%	-41.90%	-51.62%	-52.15%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).